Autopsy report · NCT00667589

Sorafenib-induced Hand- Foot Skin Reaction Treatment

“Study was halted due to poor subject accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 2 years 6 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 2 years 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Northwestern University

Sponsor type

University, hospital or other

Conditions

Hand-foot Skin Reaction; Rash

Interventions

urea 40% cream; fluocinonide 0.05% cream; tazarotene 0.1% cream; bland emollient cream (Udderly smooth® Udder Cream)

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
  “Study was halted for lack of accrual” (90% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (90% match in meaning)
• Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
  “Study stopped due to lack of accrual” (87% match in meaning)
• Pembrolizumab + Idelalisib for Lung Cancer Study
  “The study was terminated due to poor accrual.” (84% match in meaning)
• Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer
  “Study was terminated due to poor accrual” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.